Semaglutide Price in India 2026: Wegovy, Ozempic, Generics & What Actually Changed
The patent expired, dozens of generics launched and branded prices fell by up to 48%. Here is what semaglutide costs in India now, what the cheaper options really are, and what the price does not buy you.
The cost of semaglutide in India changed more in twelve months than in the whole of the preceding decade. A patent expiry, a wave of generic launches and two rounds of price cuts from the originator have reshaped what weight-loss medication actually costs here. If you last looked at prices in 2025, almost everything you knew is now out of date.
This guide sets out what semaglutide is, what the brands and generics currently cost, what the price difference does and does not buy you, and — the part most price pages skip — what determines whether the money produces a result you keep.
Before you read on
Semaglutide is a Schedule H prescription-only medicine in India. This page is general information about cost and treatment, not a recommendation, an endorsement of any brand, or an offer to supply. Prices move frequently and vary by city, pharmacy and format. We do not sell or dispense medication online.
What Semaglutide Actually Is
Semaglutide is a GLP-1 receptor agonist — an engineered version of a hormone your gut already releases after you eat. The natural hormone breaks down within minutes; the medicine is built to last about a week.
It works on appetite rather than on metabolism directly. Hunger quietens, meals feel satisfying sooner, the stomach empties more slowly, and blood sugar regulation improves. Most people eat noticeably less without the constant negotiation that dieting usually involves.
- 01Reduces appetiteFullness signalling shifts, so hunger and food noise quieten rather than needing to be resisted.
- 02Slows gastric emptyingFood leaves the stomach more gradually, extending satisfaction after a normal meal.
- 03Improves insulin responseInsulin release is better matched to what you have actually eaten.
- 04Steadies blood sugarLess glucose released by the liver between meals, easing the metabolic load.
Wegovy, Ozempic and Rybelsus: One Molecule, Three Products
This is the single most common source of confusion, and it matters commercially as well as clinically. All three contain semaglutide. They are not interchangeable.
| Product | Form | Primary licensed use |
|---|---|---|
| Wegovy | Weekly injection | Chronic weight management |
| Ozempic | Weekly injection | Type 2 diabetes |
| Rybelsus | Daily oral tablet | Type 2 diabetes |
Wegovy reaches a higher maintenance dose than Ozempic typically does, because it is dosed specifically for weight. Ozempic is frequently requested by name for weight loss, but where weight management is the primary goal, Wegovy is usually the more appropriate licensed option. Which is right for you is a clinical decision, not a brand preference.
What Changed in 2026
Three things happened in quick succession, and together they cut the cost of semaglutide treatment in India dramatically.
- 01November 2025 — first price cutNovo Nordisk reduced Wegovy MRPs by roughly a third, partly reflecting a change in the national sales tax structure.
- 0220 March 2026 — patent expiryThe Indian patent on semaglutide lapsed, opening the market to generic manufacturers.
- 03From late March 2026 — generic waveDozens of generic semaglutide brands launched from manufacturers including Sun Pharma, Dr Reddy's, Cipla, Zydus, Glenmark, Alkem and Natco.
- 04April 2026 — second price cutNovo Nordisk cut branded prices again, by up to roughly 48% across strengths, to compete with the new entrants.
For context on why this happened: Mounjaro (tirzepatide) had become India's top-selling drug by value by October 2025. Novo Nordisk was competing on two fronts at once — a stronger rival brand above, and low-cost generics arriving below.
Why this matters for you
A treatment that was financially out of reach for many patients in 2025 is, for some doses, roughly a quarter of its former cost. If affordability was your reason for ruling medication out, that reasoning is worth revisiting with current numbers.
Semaglutide Prices in India
The figures below reflect widely reported pricing following the April 2026 revision. Treat them as indicative reference points, not quotations — MRP varies by pharmacy, city and format, and this market has moved repeatedly.
Branded Wegovy — approximate monthly cost
| Strength | Approximate monthly MRP | Stage |
|---|---|---|
| 0.25 mg | From about ₹5,660 | Starting dose |
| 0.5 mg | About ₹7,200–8,800 | Early titration |
| 1 mg | About ₹8,800–10,800 | Mid titration |
| 1.7 mg | About ₹12,000–14,400 | Higher dose |
| 2.4 mg | About ₹15,200–16,400 | Maintenance dose |
Generic semaglutide
Reported generic pricing in 2026 has ranged from roughly ₹1,300 to ₹4,200 per month depending on manufacturer and dose, with some vial presentations reported from around ₹325–750 per weekly injection. That is a substantial gap from the branded product.
The critical caveat on generics
Many generic semaglutide products launched in India are approved for the management of type 2 diabetes, not for chronic weight management. A cheaper generic is therefore not automatically a substitute for Wegovy, and switching is a decision for your prescriber — not a shopping choice.
Are Generics the Same Medicine?
An approved generic contains the same active molecule and must meet the same regulatory standards for quality and manufacturing. In that sense, yes.
But three practical differences are worth understanding before you assume equivalence.
- Licensed indication — many generics are approved for diabetes, not for weight management specifically
- Device and presentation — vials versus prefilled pens differ in convenience, dosing accuracy and injection technique
- Dose range — a product licensed for diabetes may not offer the higher strengths used in weight management
- Supply consistency — a new entrant may not have the distribution reliability of an established brand, which matters when you need uninterrupted weekly supply
None of this means generics are a poor choice. It means the comparison is more complex than price per milligram, and it is exactly the sort of thing a prescriber should be weighing with you.
Semaglutide or Tirzepatide?
The other question patients arrive with. Tirzepatide — sold as Mounjaro — acts on two receptors, GLP-1 and GIP, rather than one.
| Semaglutide (Wegovy) | Tirzepatide (Mounjaro) | |
|---|---|---|
| Receptors | GLP-1 | GLP-1 and GIP |
| Average trial weight reduction | About 13.7% in a head-to-head trial over 72 weeks | About 20.2% in the same trial |
| Generic available in India | Yes, since March 2026 | No — still under patent |
| Approximate monthly cost | From about ₹5,660 branded; generics lower | About ₹13,125 to ₹25,781 |
Tirzepatide produced greater average weight reduction in direct comparison. That does not automatically make it the right choice for you: reflux, diabetes status, tolerance, budget and supply all feed into the decision, and semaglutide at a sustainable cost you can maintain for a year beats tirzepatide you stop after two months.
The Real Total Cost of Treatment
The medicine is not the whole bill, and budgeting only for the pen is how people end up abandoning treatment halfway through.
| Cost element | What it covers |
|---|---|
| Medication | The weekly injection, at whatever dose you settle on |
| Consultations | Initial assessment plus ongoing review while on treatment |
| Blood tests | Baseline and periodic monitoring |
| Nutrition support | Dietetic input, which is what protects muscle while weight falls |
| Maintenance phase | Continued support after the weight comes off, where results are kept or lost |
Budget for the taper, not just the titration
Appetite returns when medication stops, and weight commonly returns with it. Treatment that ends abruptly because the budget ran out tends to undo itself. Plan the full course — including a supported step-down — before you start.
How to Choose Sensibly
- 01Start with assessment, not with a brandEligibility, contraindications and your current medications determine what is appropriate. Arriving having already decided on a product narrows your options rather than widening them.
- 02Check the licensed indicationAsk specifically whether the product being offered is approved for weight management or for diabetes, and what that means for your dose range.
- 03Ask what the quoted figure coversA monthly figure and a per-dose figure look similar and mean very different things. Confirm which you are being given.
- 04Buy only through legitimate channelsFalsified GLP-1 pens are a documented and growing international problem. Price that looks too good usually is.
- 05Plan for the nutrition alongside itRapid weight loss without adequate protein and resistance training costs you muscle, which makes regain both easier and more likely.
Key takeaways
- Semaglutide's Indian patent expired in March 2026, and dozens of generics followed.
- Novo Nordisk cut branded Wegovy prices twice — most recently by up to about 48% in April 2026.
- Wegovy now starts from roughly ₹5,660 a month at the 0.25 mg dose; generics have been reported considerably lower.
- Many generics are licensed for diabetes rather than weight management — cheaper is not automatically equivalent.
- Tirzepatide showed greater average reduction in head-to-head trials, but has no Indian generic and costs more.
- Medication is roughly half the equation. Nutrition, monitoring and a maintenance plan decide whether the result lasts.
From our channel
Frequently asked
How much does semaglutide cost in India in 2026?
Branded Wegovy starts from roughly ₹5,660 a month at the 0.25 mg dose and runs to about ₹15,200–16,400 at the 2.4 mg maintenance dose, following the April 2026 price revision. Generic semaglutide has been reported from roughly ₹1,300 to ₹4,200 per month. Prices move frequently — confirm current figures before planning.
Why did Wegovy get cheaper in India?
Two reasons. The Indian patent on semaglutide expired on 20 March 2026, allowing dozens of generic manufacturers to enter the market, and Novo Nordisk responded with price cuts — roughly a third in November 2025 and up to about 48% more in April 2026.
Is generic semaglutide safe?
An approved generic contains the same molecule and must meet the same regulatory standards. The more important question is what indication it is licensed for and what dose range it offers, since many Indian generics are approved for type 2 diabetes rather than weight management.
Can I switch from Wegovy to a generic to save money?
That is a decision for your prescriber, not a substitution you should make yourself. Licensed indication, available strengths and device type all differ, and your dose may not translate directly.
What is the difference between Ozempic and Wegovy?
Same active ingredient — semaglutide. Ozempic is licensed primarily for type 2 diabetes and typically dosed lower; Wegovy is licensed and dosed specifically for chronic weight management.
Is Mounjaro better than Wegovy?
In a head-to-head trial over 72 weeks, tirzepatide produced greater average weight reduction — about 20.2% versus about 13.7%. Averages are not predictions, and the appropriate choice depends on your health picture, tolerance and what you can sustain financially.
Do I need a prescription for semaglutide in India?
Yes. It is a Schedule H prescription-only medicine. It cannot legally be sold without a valid prescription, and we do not dispense it online.
How long will I need to take it?
It varies. Some patients continue long term, others taper with a structured maintenance plan. This is reviewed at every follow-up rather than decided once at the start.
What happens to my weight if I stop?
Appetite returns and weight commonly returns with it. This is the medicine wearing off, not a failure of willpower — which is why any planned stop should be tapered alongside a maintenance strategy.
Is the cheapest option the best value?
Not necessarily. Value is the total cost of a course you can actually complete, including monitoring and nutrition support. Treatment abandoned at month three because the budget ran out is more expensive than a sustainable plan.
Are these medicines covered by insurance in India?
Coverage for weight-management medication is limited and varies considerably by policy. Check directly with your insurer rather than assuming.
Does The Prime Fit sell semaglutide?
No. Eligibility and prescribing are confirmed at a medical consultation. We do not sell or dispense medication online, and we would strongly advise against buying from unauthorised sellers.
Book your consultation
Send your details and we will confirm a time. BMI is worked out for you.